Linked Life Data

12528309

Source:http://linkedlifedata.com/resource/pubmed/id/12528309

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2003-1-16
pubmed:abstractText
Berlex (a Schering subsidiary) and Pfizer (formerly Parke-Davis) are developing ZK-807834 (CI-1031), one of a series of Factor Xa inhibitors, for the potential parenteral treatment of unstable angina pectoris.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1472-4472
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1736-41
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
ZK-807834. Berlex.
pubmed:affiliation
Millennium Pharmaceuticals Inc, 256 East Grand Avenue, South San Francisco, CA 94080, USA. uma.sinha@mpi.com
pubmed:publicationType
Journal Article, Review